Special teams formed to monitor drug firms in TN, says Minister Subramanian
- byDoctor News Daily Team
- 18 October, 2025
- 0 Comments
- 0 Mins
In response to the tragic deaths of about 25 infants in Madhya Pradesh linked to a toxic cough syrup, Tamil Nadu has formed special teams to continuously monitor drug manufacturers, with a focused inspections conducted at nearly 50 pharmaceutical companies. Health Minister Ma Subramanian revealed that the inspections have already targeted 50 firms out of the state’s 397. The move comes after reports of the deadly cough syrup manufactured by a Tamil Nadu-based company, Sresan Pharmaceuticals, being linked to the fatalities.
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Tags:
Recent News
AIIMS INI SS January 2026: 4 seats added in 2 spec...
- 01 November, 2025
Treatment in Myocardial Infarction and Non-Obstruc...
- 01 November, 2025
PG medical admissions 2025 commence in Bihar, chec...
- 01 November, 2025
Assam to begin NEET PG 2025 counselling from Novem...
- 01 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!